Ken Burns is VP of Commercial who partners with customers from all industries to bring their products from 2D to 3D. After spending nearly a decade working in Additive Manufacturing for multimillion dollar brands and startups, Ken knows what truly drives the successful integration of 3D Printing into the product development lifecycle, and beyond—and it’s not about chasing the latest 3D Printing buzz. It’s about turning use-cases into business-cases and successfully communicating that message.
Ken has first-hand experience with SLA, FDM, PolyJet, MJF, SLS, DMLS and Projet at two different service providers. He worked as a Materials Business Manager for Stratasys which provided him with insights as both a customer and OEM.
Ken holds a BS in Psychology and Political Science from Pepperdine University.
Sean Burke is partner at Duane Morris in their Washington, DC office. Mr. Burke’s practice focuses on representation of manufacturers of medical devices in products liability cases across the country, including in consolidated multi-plaintiff matters in both federal court and state courts in California, Illinois, and Tennessee. His experience includes defense of large total joint replacements (hips, knees, ankles, and shoulders) and resurfacings, tissue matrices and patches, fusion plates, and surgical instruments. He has a particular interest and recent focus on additive manufacturing, consulting and advising clients on best practices in the early stages of development to reduce risk of products liability exposure. He has tried medical device cases before juries in both state and federal courts while also handling numerous mediations. He works closely with scientific experts to advance causation and liability defenses in the areas of biomechanical engineering, toxicology, histology, epidemiology, orthopedic surgery and FDA regulations.
He is admitted to practice in the District of Columbia, Pennsylvania and New Jersey as well as six different United States District Courts. Prior to rejoining Duane Morris, Mr. Burke served as law clerk for the Honorable Joel H. Slomsky of the U.S. District Court for the Eastern District of Pennsylvania. He is a magna cum laude graduate of Villanova University School of Law and a cum laude graduate of Catholic University of America.
Geoffrey Doyle is Business Development Director for Jabil Additive and has spent 20 years as an investor and entrepreneur. Geoffrey is a founder of, an investor in and advisor to several metal 3D printing/implant companies. He has been a key driver of Jabil’s Additive Manufacturing healthcare Strategy. Prior to joining Jabil Geoffrey was president of FIT West and netfabb US, prior to this he spent over a decade investing in UK technology companies.
He holds a bachelor’s degree in mechanical engineering & MBA from the University of Manchester and is a Sandhurst graduate.
Lauralyn McDaniel joined ASME in February 2019 as Industry Events Manager and leads ASME’s new Medical AM/3DP Advisors. She was previously the industry manager of medical device manufacturing at SME.
McDaniel has been involved in medical manufacturing since 2000 and additive manufacturing since 1999, engaging with companies and activities surrounding additive manufacturing, micromanufacturing, nanotechnology, and many other technologies. This work has included identifying challenges and potential solutions for medical manufacturing, writing articles on innovative technologies and processes, and leading a Medical Additive/3D Printing groups as well as an Innovation Watch Committee. She has been active with the additive manufacturing community since 1999 and serves as Vice Chair of the America Makes & ANSI Additive Manufacturing Standards Collaborative as well as co-chair of the Medical Workgroup, and is a member of DICOM WG-17 3D Manufacturing, RSNA 3D Printing SIG, and ASTM F42 Executive Committee. She received the America Makes Ambassador Award in 2018 and was named the 3D Printing Industry’s Community Advocate of the Year in 2019. She has written several articles focusing on the challenges to expanding the application of AM3DP in medicine including scale-up of bioprinting and the workforce needed to support the technology.
She holds a BA from Oakland University and an MBA from the University of Notre Dame.
Sam Wainwright, dental product manager at Formlabs, has been in the dental industry for 10+ years helping labs and dentists become more effective with new technology. He most notably has worked for Custom Automated Prosthetics (CAP), Henry Schein, and 3M/Brontes Technologies as they expanded their presence in the industry.
Stephen Anderson PhD CEng MBCS MInstP obtained his doctorate from the University of Lancaster, UK (1993) and worked at the University of Bristol, UK in research and as Academic Director of Computing. He joined Renishaw in 2000 as Internet Development Manager switching into Group Engineering in 2007 and becoming Group Software Director in 2011. With 17 years’ systems software experience, he delivered much of the Group’s Software portfolio across its Industrial Metrology, Healthcare and Additive Manufacturing businesses, from probing software to neurosurgery and Renishaw’s own AM build preparation software QuantAM. In 2017 Stephen took up a new role as AM Business Development Manager – USA where he is responsible for all aspects of Renishaw’s AM product line in the US
As the Director of Device Development at Hospital for Special surgery (HSS) I have over thirty years of medical research and device development experience. I have worked with multiple services at HSS including Adult Hip and Knee Replacement, Foot and Ankle, Hand and Upper Extremity, Hip Preservation, Spine and Sports Medicine. In working with these services and the Biomechanics department, I’ve contributed to the development of implants for the knee, hip, elbow and spine. These implants have been licensed to several orthopedic companies and are sold worldwide. I am an inventor of twenty-five patented medical devices and have multiple publications in the medical device area. In addition, I am a registered US Patent Agent.
Duncan is an experienced CEO and investor with over two decades of success launching and leading new ventures. As an entrepreneur and CEO, Duncan has co-founded, built and sold two companies (Cilk Arts, VeloBit). Previously, Duncan served as a venture capitalist at Bessemer Venture Partners and Flagship Ventures, leading investments in 16 companies that have produced 12 acquisitions and an aggregate market capitalization in excess of $1.5 billion. Early in his career, Duncan led control system research teams at Draper Laboratory. He holds two degrees from MIT and an MBA from Harvard Business School.